Targeting the Residual Leukemia Cells after Chemotherapy.
Sign Up to like & getrecommendations! Published in 2018 at "Cancer cell"
DOI: 10.1016/j.ccell.2018.08.012
Abstract: One of the biggest challenges in treating acute myeloid leukemia (AML) is relapse of aggressive disease after treatment. In this issue of Cancer Cell, Boyd et al. characterize a molecularly distinct population of chemotherapy-induced transient leukemic regenerating… read more here.
Keywords: targeting residual; residual leukemia; leukemia cells; cells chemotherapy ... See more keywords